Trevi Therapeutics (TRVI) had the highest return between April 13, 2023 and April 30, 2023 by a small-cap US stock, returning 88%.
| ASSET | DATE | % RETURN |
|---|---|---|
Trevi Therapeutics (TRVI) | 4/13/2023 - 4/30/2023 | 87.98% |
Eyepoint Pharmaceuticals (EYPT) | 4/13/2023 - 4/30/2023 | 86.35% |
Tourmaline Bio (TRML) | 4/13/2023 - 4/30/2023 | 57.38% |
Checkpoint Therapeutics (CKPT) | 4/13/2023 - 4/30/2023 | 57.14% |
Disc Medicine (IRON) | 4/13/2023 - 4/30/2023 | 52.3% |
Edgewise Therapeutics (EWTX) | 4/13/2023 - 4/30/2023 | 51.99% |
Akebia Ther (AKBA) | 4/13/2023 - 4/30/2023 | 45.83% |
Sana Biotechnology (SANA) | 4/13/2023 - 4/30/2023 | 38.48% |
Akso Health Group ADR (AHG) | 4/13/2023 - 4/30/2023 | 38.2% |
Ideaya Biosciences (IDYA) | 4/13/2023 - 4/30/2023 | 36.17% |
Olema Pharmaceuticals (OLMA) | 4/13/2023 - 4/30/2023 | 35.31% |
Regulus Therapeutics (RGLS) | 4/13/2023 - 4/30/2023 | 32.18% |
Pulse Biosciences (PLSE) | 4/13/2023 - 4/30/2023 | 31.7% |
Oculis Holding AG Ordinary shares (OCS) | 4/13/2023 - 4/30/2023 | 30.94% |
American Coastal Insurance (ACIC) | 4/13/2023 - 4/30/2023 | 30.7% |
IperionX Limited American Depositary Share (IPX) | 4/13/2023 - 4/30/2023 | 30.45% |
Mereo BioPharma Group PLC ADR (MREO) | 4/13/2023 - 4/30/2023 | 29.7% |
LENZ Therapeutics (LENZ) | 4/13/2023 - 4/30/2023 | 29.69% |
Terawulf (WULF) | 4/13/2023 - 4/30/2023 | 28.99% |
Centessa Pharmaceuticals PLC ADR (CNTA) | 4/13/2023 - 4/30/2023 | 28.96% |
Beazer Homes USA (BZH) | 4/13/2023 - 4/30/2023 | 28.92% |
Lindblad Expeditions (LIND) | 4/13/2023 - 4/30/2023 | 28.82% |
UroGen Pharma (URGN) | 4/13/2023 - 4/30/2023 | 27.5% |
Magnera Corp placeholder (MAGN) | 4/13/2023 - 4/30/2023 | 27.32% |
Mind Medicine (MNMD) | 4/13/2023 - 4/30/2023 | 26.91% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
